Avidity Partners Management LP
DALLAS, TX · CIK 1791827 · 13F filing filed 2024-08-14
SEC-registered investment adviser since 2020 · limited partnership
- Assets managed$1.1bn
- Staff9 · 7 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 (3 hedge) · $1.1bn gross assets
- Form ADV · 2026-03-31SEC adviser record
- Legal entityAVIDITY PARTNERS MANAGEMENT LP (US)
- Kindhedge funds
- Others nearbyDallas, TX, New York, NY
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Dallas, TX (main office)United States | about 5 |
| New York, NYUnited States | 2 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| INTUITIVE SURGICAL INC ISRG | $109.0m4.63% | Added +19.0k |
| BOSTON SCIENTIFIC CORP BSX | $90.1m3.83% | Reduced -785.9k |
| NATERA INC NTRA | $83.0m3.53% | Reduced -36.8k |
| ARVINAS INC ARVN | $79.5m3.38% | Added +2.7k |
| ACADIA HEALTHCARE COMPANY IN ACHC | $75.6m3.21% | Added +115.0k |
| DIANTHUS THERAPEUTICS INC DNTH | $75.5m3.21% | Added +199.7k |
| SYNDAX PHARMACEUTICALS INC SNDX | $68.5m2.91% | Added +922.5k |
| NEUROCRINE BIOSCIENCES INC NBIX | $67.6m2.87% | Reduced -45.5k |
| AVANTOR INC AVTR | $65.4m2.78% | Added +391.0k |
| THE CIGNA GROUP CI | $61.0m2.59% | Unchanged |
| JAZZ PHARMACEUTICALS PLC JAZZ | $58.1m2.47% | Reduced -39.5k |
| ALNYLAM PHARMACEUTICALS INC ALNY | $53.9m2.29% | Reduced -21.0k |
| REGENERON PHARMACEUTICALS REGN | $50.4m2.14% | Reduced -20.0k |
| ILLUMINA INC ILMN | $49.9m2.12% | Added +13.9k |
| TENET HEALTHCARE CORP THC | $49.5m2.10% | Reduced -229.0k |
| ABBVIE INC ABBV | $47.6m2.02% | Added +50.8k |
| THERMO FISHER SCIENTIFIC INC TMO | $44.2m1.88% | Added +43.4k |
| STRUCTURE THERAPEUTICS INC GPCR | $42.2m1.79% | Added +211.0k |
| BLUEPRINT MEDICINES CORP BPMC | $41.3m1.75% | Reduced -43.0k |
| CG ONCOLOGY INC CGON | $40.9m1.74% | Reduced -158.5k |
| MERCK & CO INC MRK | $40.2m1.71% | Reduced -177.0k |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $39.5m1.68% | Added +26.5k |
| IDEAYA BIOSCIENCES INC IDYA | $39.2m1.67% | Added +317.3k |
| DANAHER CORPORATION DHR | $37.5m1.59% | Added +6.2k |
| JANUX THERAPEUTICS INC JANX | $35.2m1.50% | Added +456.0k |
| UNITED THERAPEUTICS CORP DEL UTHR | $35.0m1.49% | Reduced -107.0k |
| INCYTE CORP INCY | $32.1m1.36% | New |
| SURGERY PARTNERS INC SGRY | $31.1m1.32% | Reduced -138.5k |
| PERSPECTIVE THERAPEUTICS INC CATX | $30.3m1.29% | New |
| AXSOME THERAPEUTICS INC AXSM | $30.3m1.29% | Reduced -55.0k |
| XENON PHARMACEUTICALS INC XENE | $29.4m1.25% | Added +44.0k |
| DEXCOM INC DXCM | $29.4m1.25% | Added +82.1k |
| REVOLUTION MEDICINES INC RVMD | $29.3m1.25% | Added +120.0k |
| INSMED INC INSM | $28.8m1.22% | New |
| INTRA-CELLULAR THERAPIES INC ITCI | $27.4m1.16% | Reduced -200.0k |
| CULLINAN THERAPEUTICS INC CGEM | $27.2m1.16% | New |
| GLAUKOS CORP GKOS | $26.5m1.13% | Unchanged |
| NEUROGENE INC NGNE | $26.5m1.12% | Added +262.3k |
| ARGENX SE ARGX | $26.0m1.11% | New |
| MIRUM PHARMACEUTICALS INC MIRM | $25.0m1.06% | Reduced -411.7k |
| ESTABLISHMENT LABS HLDGS INC ESTA | $24.1m1.03% | Added +306.0k |
| IMMUNOVANT INC IMVT | $24.0m1.02% | Added +403.0k |
| ROCKET PHARMACEUTICALS INC RCKT | $23.7m1.01% | Added +75.0k |
| LANTHEUS HLDGS INC LNTH | $23.3m0.99% | Reduced -190.0k |
| VAXCYTE INC PCVX | $21.4m0.91% | Unchanged |
| APOGEE THERAPEUTICS INC COM | $19.2m0.81% | Added +102.1k |
| JASPER THERAPEUTICS INC JSPR | $17.8m0.75% | Added +22.0k |
| NEUMORA THERAPEUTICS INC. NMRA | $17.7m0.75% | Unchanged |
| LEGEND BIOTECH CORP LEGN | $17.6m0.75% | Reduced -270.3k |
| GILEAD SCIENCES INC GILD | $17.5m0.74% | New |
| PHATHOM PHARMACEUTICALS INC PHAT | $16.7m0.71% | Reduced -115.0k |
| ASTRAZENECA PLC SPONSORED ADR | $16.0m0.68% | Added +45.0k |
| KEROS THERAPEUTICS INC KROS | $15.7m0.67% | Added +133.5k |
| BIOHAVEN LTD BHVN | $15.6m0.66% | Added +375.0k |
| SANOFI SNY | $15.3m0.65% | New |
| REGENXBIO INC RGNX | $15.2m0.65% | Unchanged |
| CONTEXT THERAPEUTICS INC CNTX | $14.9m0.63% | New |
| EXACT SCIENCES CORP EXAS | $14.3m0.61% | New |
| PRIVIA HEALTH GROUP INC PRVA | $13.3m0.56% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $10.7m0.46% | Added +84.3k |
| IMMUNOME INC IMNM | $10.6m0.45% | Unchanged |
| IMMUNIC INC COM | $9.9m0.42% | Unchanged |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $9.8m0.41% | New |
| CYBIN INC COM | $9.5m0.40% | Unchanged |
| SYROS PHARMACEUTICALS INC SYRS | $8.6m0.37% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $8.4m0.36% | Added +555.0k |
| IMMUNOCORE HLDGS PLC IMCR | $6.8m0.29% | Reduced -86.4k |
| TYRA BIOSCIENCES INC TYRA | $6.0m0.25% | New |
| UIPATH INC PATH | $4.6m0.20% | New |
| SPYRE THERAPEUTICS INC SYRE | $4.6m0.19% | New |
| IMMATICS N.V IMTX | $4.6m0.19% | New |
| IONIS PHARMACEUTICALS INC IONS | $4.4m0.19% | Reduced -37.0k |
| ARCA BIOPHARMA INC COM | $3.8m0.16% | New |
| EDITAS MEDICINE INC EDIT | $3.8m0.16% | New |
| INTELLIA THERAPEUTICS INC NTLA | $3.8m0.16% | New |
| COLLEGIUM PHARMACEUTICAL INC COLL | $3.8m0.16% | Reduced -244.4k |
| PRIME MEDICINE INC PRME | $3.6m0.15% | Reduced -1.3m |
| AC IMMUNE SA ACIU | $3.3m0.14% | Reduced -3.6m |
| KEZAR LIFE SCIENCES INC COM | $3.0m0.13% | Unchanged |
| SCYNEXIS INC COM NEW | $2.9m0.12% | Unchanged |
| KARYOPHARM THERAPEUTICS INC COM | $1.8m0.07% | Reduced -6.3m |
| WAVE LIFE SCIENCES LTD 96663EUR | $1.7m0.07% | New |
| HYPERFINE INC HYPR | $1.0m0.04% | Unchanged |
| CAREMAX INC CL A NEW | $59.1k0.00% | Unchanged |
| NUVATION BIO INC NUVB.WS | $1.9k0.00% | Reduced -77.4k |
Sold out since Q1 2024
| Security | Value then |
|---|---|
| FUSION PHARMACEUTICALS INC | $138.6m6.5m shares |
| ALIGN TECHNOLOGY INC ALGN | $62.0m189.0k shares |
| ELI LILLY & CO LLY | $54.5m70.0k shares |
| ALPINE IMMUNE SCIENCES INC NVLS | $46.6m1.2m shares |
| CVS HEALTH CORP CVS | $43.5m545.0k shares |
| CARIBOU BIOSCIENCES INC CRBU | $29.7m5.8m shares |
| MCKESSON CORP MCK | $17.9m33.3k shares |
| VERA THERAPEUTICS INC VERA | $16.5m383.5k shares |
| ASTRIA THERAPEUTICS INC CATB | $13.8m982.0k shares |
| CYTOKINETICS INC CYTK | $11.6m166.0k shares |
| RADNET INC RDNT | $11.6m238.0k shares |
| ACADIA PHARMACEUTICALS INC ACAD | $10.9m588.5k shares |
| CENTURY THERAPEUTICS INC IPSC | $5.1m1.2m shares |
| KYVERNA THERAPEUTICS INC KYTX | $5.0m202.3k shares |
| EMERGENT BIOSOLUTIONS INC EBS | $4.8m1.9m shares |
| AN2 THERAPEUTICS INC ANTX | $3.7m1.1m shares |
| GINKGO BIOWORKS HOLDINGS INC | $3.5m3.0m shares |
| X4 PHARMACEUTICALS INC | $3.4m2.4m shares |
| PACIFIC BIOSCIENCES CALIF IN PACB | $2.5m675.0k shares |
| KODIAK SCIENCES INC KOD | $1.6m300.0k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| IMMUNIC INC 13G · filed 2026-04-17 | 9.9% |
| CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2026-05-12 | 8.7%≈ $4.6m |
| PERSPECTIVE THERAPEUTICS INC CATX · 13G · filed 2026-03-10 | 5.3%≈ $20.6m |